The Community Guide

- gsearch

Search Results

Narrow Results:

2017 1
2016 1
2015 1
2011 2

National Centr for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. 1

United States 1

Journal Article 4

1 - 5 of 5 Results

Refine Results

Refine Results:

Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009

CITE Title : Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009 Personal Author(s) : Winston, Carla A.;Navin, Thomas R.;Becerra, Jose E.;Chen, Michael P.;Armstrong, Lori R.;Jeffries, Carla;Yelk Woodruff, Rachel S;Wing, Jessie;Starks, Angela M.;Hales, Craig M.;Kammerer, J. Steve;Mac Kenzie, William R.;Mitruka, Kiren;Miner, Mark C.;Price, Sandy;Scavotto, Joseph;Cronin, Ann M.;Griffin, Phillip;LoBue, Philip A.;Castro, Kenneth G.; Published Date : Nov 07 2011 Source : BMC Public Health. 2011; 11:846. URL : https://stacks.cdc.gov/view/cdc/3437 Winston, Carla A. et al. (2011). Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009. 11 Winston, Carla A. et al. "Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009" 11 (2011) Winston, Carla A. et al. "Unexpected decline in tuberculosis cases coincident with economic recession -- United States, 2009" vol. 11, 2011 Export RIS Citation Information.

:

Winston, Carla A. ;

Navin, Thomas R.

Nov 07 2011 | BMC Public Health. 2011; 11:846.

:

BackgroundSince 1953, through the cooperation of state and local health departments, the U.S. Centers for Disease Control and Prevention (CDC) has col...
Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States

CITE Title : Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States Personal Author(s) : Yakrus, Mitchell A.;Driscoll, Jeffrey;McAlister, Allison;Sikes, David;Hartline, Denise;Metchock, Beverly;Starks, Angela M.; Published Date : Jun 08 2016 Source : Tuberc Res Treat. 2016; 2016. URL : https://stacks.cdc.gov/view/cdc/40631 Yakrus, Mitchell A. et al. (2016). Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States. 2016 Yakrus, Mitchell A. et al. "Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States" 2016 (2016) Yakrus, Mitchell A. et al. "Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United States" vol. 2016, 2016 Export RIS Citation Information.

:

Yakrus, Mitchell A. ;

Driscoll, Jeffrey

Jun 08 2016 | Tuberc Res Treat. 2016; 2016.

:

Ethambutol (EMB) is used as a part of drug regimens for treatment of tuberculosis (TB). Susceptibility of Mycobacterium tuberculosis complex (MTBC) is...
Evaluation of a U.S. Public Health Laboratory Service for the Molecular Detection of Drug Resistant Tuberculosis

CITE Title : Evaluation of a U.S. Public Health Laboratory Service for the Molecular Detection of Drug Resistant Tuberculosis Personal Author(s) : Yakrus, Mitchell A.;Metchock, Beverly;Starks, Angela M.; Published Date : Feb 22 2015 Source : Tuberc Res Treat. 2015; 2015. URL : https://stacks.cdc.gov/view/cdc/29012 Yakrus, Mitchell A. et al. (2015). Evaluation of a U.S. Public Health Laboratory Service for the Molecular Detection of Drug Resistant Tuberculosis. 2015 Yakrus, Mitchell A. and Metchock, Beverly and Starks, Angela M. "Evaluation of a U.S. Public Health Laboratory Service for the Molecular Detection of Drug Resistant Tuberculosis" 2015 (2015) Yakrus, Mitchell A. et al. "Evaluation of a U.S. Public Health Laboratory Service for the Molecular Detection of Drug Resistant Tuberculosis" vol. 2015, 2015 Export RIS Citation Information.

:

Yakrus, Mitchell A. ;

Metchock, Beverly

Feb 22 2015 | Tuberc Res Treat. 2015; 2015.

:

Crucial to interrupting the spread of tuberculosis (TB) is prompt implementation of effective treatment regimens. We evaluated satisfaction, comfort w...
Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis

CITE Title : Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis Personal Author(s) : Campbell, Patricia J.;Morlock, Glenn P.;Sikes, R. David;Dalton, Tracy L.;Metchock, Beverly;Starks, Angela M.;Hooks, Delaina P.;Cowan, Lauren S.;Plikaytis, Bonnie B.;Posey, James E.; Published Date : May 2011 Source : Antimicrobial Agents and Chemotherapy. 2011; 55(5):2032-2041. URL : https://stacks.cdc.gov/view/cdc/4393 Campbell, Patricia J. et al. (2011). Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis. Campbell, Patricia J. et al. "Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis" (2011) Campbell, Patricia J. et al. "Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis" , 2011 Export RIS Citation Information.

:

Campbell, Patricia J. ;

Morlock, Glenn P.

May 2011 | Antimicrobial Agents and Chemotherapy. 2011; 55(5):2032-2041.

:

The emergence of multi- and extensively drug-resistant tuberculosis is a significant impediment to the control of this disease because treatment becom...
Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017

CITE Title : Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017 Personal Author(s) : Stafford, Cortney;Metchock, Beverly;Johnston, Stephanie;Diem, Lois;Yakrus, Mitchell A.;Starks, Angela M.; Corporate Authors(s) : National Centr for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. Published Date : September 2017 Pages in Document : 29 numbered pages Series : Model Performance Evaluation Program (MPEP) Report URL : https://stacks.cdc.gov/view/cdc/77952 Stafford, Cortney et al. (2017). Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017. Stafford, Cortney et al. "Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017" (2017) Stafford, Cortney et al. "Mycobacterium Tuberculosis Complex Drug Susceptibility Testing Program: Model Performance Evaluation Program Report of Results August 2017" , 2017 Export RIS Citation Information.

:

Stafford, Cortney ;

Metchock, Beverly

September 2017 | Model Performance Evaluation Program (MPEP) Report

:

The Model Performance Evaluation Program (MPEP) is an educational self-assessment tool in which five isolates of M. tuberculosis complex (MTBC) are se...